Last Updated: 05/07/08
Quality Education for
Quality Care
Continuing
Education
|
||||||||
 For PDF viewing, download Adobe Acrobat Reader |
||||||||
|
LIVE PROGRAMS
A Complimentary
Dinner Symposium to be Held in Conjunction with Geratrics
’08, ASCP’s 30th Midyear Conference and Exhibition
”Optimizing Outcomes in the Elderly Patient: A Guide for the Pharmacologic Management of GERD” Wednesday, May 14, 2008 7:15 PM – 9:15 PM Caesars Palace Las Vegas, Nevada This program offers 0.2 CEU (2 contact hours).
And
“Management of Moderate-to-Severe Psoriasis: The Role of the Physician Assistant” Sunday, May 25, 2008 5:30 PM – 8:00 PM Henry B. Gonzalez Convention Center Room 217 A/B San Antonio, Texas This program has been reviewed and is approved for a maximum of 2 hours of AAPA Category I CME credit by the Physician Assistant Review Panel.
|
||||||||
NEW!
Phytosterols and Cardiovascular Health: What Healthcare Professionals Need to Know
The goal of this activity is to educate health professionals about the various phytosterols (plant sterols), their modes of action in the reduction of blood cholesterol levels, and implications for their use in supplementing cardiovascular health.
|
|
|
NEW!
Chronic Pain: A Consultative Approach
The goals of this program are to provide readers with current information on effective strategies for optimizing control of chronic pain in the community dwelling patient, with emphasis on improving quality of life with effective patient education.
|
|
|
NEW!
Direct Renin Inhibitors: A Novel Approach to Hypertension
Management
The goal of this continuing education activity will be to provide healthcare professionals with an overview of the role of direct renin inhibition in the management of hypertension. This activity will identify and discuss a new drug class aimed at blocking renin, and examine the differences between these new agents and current treatment. This activity will emphasize the role of the healthcare provider in intervening and educating patients to improve medication adherence and patient outcomes.
|
|
|
Appropriate Use and Risk Management of Opioids
The goal of this lesson is to discuss the therapeutic use of opioids, emphasizing important pharmacokinetic and pharmacodynamic characteristics and risk management issues.
|
|
|
Treating Colorectal Cancer in the Elderly Population - HTML version only
The goal of this continuing education activity is to provide healthcare professionals with the information necessary to treat elderly patients with colorectal cancer.
|
|
|
What Patients Should Know About Treating and Managing Rosacea
The goal of this program is to present current information on the diagnosis, classification of symptoms, and the medications used to treat and manage rosacea.
|
|
|
Special Considerations for Treating GERD Patients in the Long-Term Care Setting
This activity is designed to update pharmacists, physicians, nurse practitioners, physician assistants, and nurses with special interest in the treatment of gastroesophageal reflux disease in (GERD) the long-term care setting.
|
|
|
New Findings in Osteoarthritis: Etiology and Treatment - HTML version only
The goal of this monograph is to discuss current concepts relative to the etiology and treatment of osteoarthritis (OA). Discussion will concentrate on the inflammatory component of osteoarthritis and its therapy with nonsteroidal anti-inflammatory drugs (NSAIDs), particularly those available without a prescription.
|
|
|
New Drugs and Biologicals Approved During July '05 Through June '06
This program provides information on new drugs and biological agents approved during the period 7/1/05 through 6/30/06, including advice to convey to patients to maximize treatment outcomes. Emphasis is on new molecular entity drugs.
|
|
|
Pharmacy Law: The Role of the Pharmacist Regarding Behind-the-Counter
Pseudoephedrine Cold and Sinus Products
- 
Version 5.0
The goal of this lesson is to provide pharmacists and interested nurse practitioners with an understanding of recent regulatory changes regarding the availability of pseudoephedrine and its relationship to methamphetamine abuse.
|
|
|
Pharmacy Law: Medical Marijuana - HTML version only
The goal of this monograph is to review the proposed medical uses of marijuana and the effects directed towards its legalization or decriminalization.
|
|
|
Women’s Health: The Role of Aspirin in the Primary Prevention of Cardiovascular Events - HTML version only
The goal of this monograph is to present current information on the morbidity and mortality of cardiovascular events in women, describe the role of aspirin in the primary prevention of cardiovascular disease in women, and discuss issues relative to its safe and effective use for this purpose.
|
|
|
Acid Reflux in Pediatrics: Diagnosis, Associated Conditions, and Therapy
-
Version 5.0
This program will provide a comprehensive review of reflux in pediatrics serving as a refresher, enhancing awareness of related diseases, and providing an update on therapy for this patient population.
|
|
|
AIDS Update on Therapeutic Control and Patient Counseling - HTML version only
The goal of this lesson is to discuss the etiology and treatment of HIV infection and Acquired Immune Deficiency Syndrome (AIDS). The focus is directed toward providing information for pharmacists that can then be conveyed to patients and/or their caregivers regarding current therapeutic approaches and recommendations on caring for persons who are HIV-positive and those with AIDS.
|
|
|
Pharmacy Law: The Issue of Emergency Contraception -
HTML only
The goals of this lesson are to provide pharmacists with an
understanding of the use and misconceptions about emergency
contraceptive therapy and to provide a basis for appreciation of the
controversy and legal issues surrounding their proposed switch to
non-prescription status.
|
|
Improving Care of the Oncology Patient: Optimum Management of Anemia
The goal of this monograph is to present current information on the
incidence, pathology, implications, and therapeutic options for treating
anemia in the patient with cancer. Included will be a discussion of
signs and symptoms, diagnosis, when to treat, dosing and compliance,
with emphasis given to use of the erythropoietic agents to improve
patient quality of life and treatment outcomes.
|
|
|
OTC
NSAIDs: New Considerations and Options in Treating Osteoarthritis Pain
in the Pharmacy Setting
- HTML version only
The
goal of this monograph is to provide new clinical information to be
considered when choosing an appropriate OTC drug product for use in
treatment of pain due to osteoarthritis, and summarize current clinical
information on OTC pain relievers pertaining to safety issues on
cardiovascular and cerebrovascular functions.
|
|
Drugs in the News: An Overview of New
Therapies -
LIVECAST "Live
Internet Offering"
Drugs in the News: An Overview of New
Therapies -
Home Study
This webcast slide presentation
provides pharmacists with information on the pharmacology and
therapeutics of prescription drugs approved and/or recently introduced
into therapy. Focus is on FDA-approved indications and relevant data on
the drugs, including trends that will impact future drug discovery and
approval. Drugs discussed include entecavir, exenatide, galsulfase,
insulin detemir, mecasermin, micafungin, nepafenac, pramlintide,
ramelteon, tigecycline, and tipranavir.
|
|
Next Generation Therapy for Dyslipidemia: Improving CV Risk Management
-
Version 5.0
The goal of this program is to describe
the increased incidence of severe, mixed dyslipidemia; review its effect
on cardiovascular risk; and present emerging treatment options to
improve cardiovascular outcomes.
|
|
|
Preventing Medication Errors - HTML
version only
The goal of this lesson is to identify
problems associated with the medication use process and provide strategies
to eliminate or significantly reduce medication errors.
| Accreditation:
ACPE (2.0 hours) 380-000-05-026-H04 Publication Date: December 1, 2005 - Expiration Date: December 1, 2008
|
New Drugs Approved During the First Half of 2005 - HTML version only
The goal of this lesson is to provide information on new drugs approved and/or introduced into therapy during the first-half of 2005. Drugs discussed include Aptivus, Baraclude, Byetta, Enablex, Levemir, Lunesta, Mycamine, Naglazyme, Rozerem, Symlin, Tygacil, and Ventavis. Emphasis is on new molecular entities. Advice to convey to patients to maximize compliance and treatment outcomes is included.
|
|
|
Medicare
2006: Pharmacy's New Patient Counseling Role Under Medication Therapy
Management -
Version 5.0
This program will describe the potential role, responsibilities, and
opportunities for the nation's pharmacists in providing prescription drug
therapy counseling and other medication therapy management programs to
seniors as required under the Medicare Modernization Act of 2003.
|
|
|
We are currently developing new programs.
Help us provide content based on your needs. Please type your topic request in the field below and select your profession from the list box. We will do our best to meet your needs.
Copyright © 2005-2008. All
rights reserved. Reproduction in whole or in part without
written permission from The CE Solution, Inc. is strictly prohibited.